R01AG078248
Project Grant
Overview
Grant Description
The Role of Stress Exposure on Estradiol-Induced Changes in Neuroinflammation and Cognition - Abstract
The number of people suffering from age-related cognitive decline is growing at an unprecedented rate as the human lifespan increases. In addition, exposure to social adversity and other stressors increases the risk for cognitive deficits, which may be exacerbated in aging. Because women are at greater risk for developing cognitive impairment compared to men, a potential role for estradiol is implicated. However, findings from studies assessing the effects of estradiol on cognition are equivocal. Consequently, there is a need to understand whether adverse experiential factors may impact estradiol efficacy that would account for the variance in the effects of estradiol on cognitive aging in females.
One mechanism by which stress exposure and estradiol both impact cognition and memory is modulation of neuroinflammatory processes that alter neurotransmitter release and synthesis and are associated with unhealthy aging. Despite observations that chronic stress exposure increases vulnerability to cognitive decline, it is not clear whether stress-induced alterations in estradiol's efficacy in modulating neuroinflammation and cognitive behavior.
To fill this gap in knowledge, the proposed studies will leverage a well-characterized non-human primate model of psychosocial stress to test the overarching hypothesis that low social status produces cognitive deficits in female rhesus monkeys and neuroinflammation in the brain that are exacerbated by estradiol. Using social group rearrangements and estradiol manipulations, we will test the effects of social status and age on neuroinflammation by using PET neuroimaging to site-specifically quantify microglial activation in the brain, as well as measure concentrations of pro-inflammatory signals in cerebral spinal fluid. We will also determine the effects of chronic social status and age on cognitive flexibility and memory capacity and determine the extent to which neuroinflammation accounts for variance in executive function assessed.
Finally, we will determine the causal effects of social status on estradiol's ability to modulate neuroinflammation and cognition. At its conclusion, the proposed studies will extend upon our previous work by following the same individuals across experimentally determined changes in their social status to generate insight into both the causal effects of social status on estradiol's ability to influence cognitive behavior and brain region-specific markers of neuroinflammation and their plasticity with changes in the social environment. By assessing and integrating the physiological, neurobiological, and behavioral data collected as part of the proposed studies, we will be able to identify a novel mechanism underlying risk for aging-related health disparities in the female brain.
The number of people suffering from age-related cognitive decline is growing at an unprecedented rate as the human lifespan increases. In addition, exposure to social adversity and other stressors increases the risk for cognitive deficits, which may be exacerbated in aging. Because women are at greater risk for developing cognitive impairment compared to men, a potential role for estradiol is implicated. However, findings from studies assessing the effects of estradiol on cognition are equivocal. Consequently, there is a need to understand whether adverse experiential factors may impact estradiol efficacy that would account for the variance in the effects of estradiol on cognitive aging in females.
One mechanism by which stress exposure and estradiol both impact cognition and memory is modulation of neuroinflammatory processes that alter neurotransmitter release and synthesis and are associated with unhealthy aging. Despite observations that chronic stress exposure increases vulnerability to cognitive decline, it is not clear whether stress-induced alterations in estradiol's efficacy in modulating neuroinflammation and cognitive behavior.
To fill this gap in knowledge, the proposed studies will leverage a well-characterized non-human primate model of psychosocial stress to test the overarching hypothesis that low social status produces cognitive deficits in female rhesus monkeys and neuroinflammation in the brain that are exacerbated by estradiol. Using social group rearrangements and estradiol manipulations, we will test the effects of social status and age on neuroinflammation by using PET neuroimaging to site-specifically quantify microglial activation in the brain, as well as measure concentrations of pro-inflammatory signals in cerebral spinal fluid. We will also determine the effects of chronic social status and age on cognitive flexibility and memory capacity and determine the extent to which neuroinflammation accounts for variance in executive function assessed.
Finally, we will determine the causal effects of social status on estradiol's ability to modulate neuroinflammation and cognition. At its conclusion, the proposed studies will extend upon our previous work by following the same individuals across experimentally determined changes in their social status to generate insight into both the causal effects of social status on estradiol's ability to influence cognitive behavior and brain region-specific markers of neuroinflammation and their plasticity with changes in the social environment. By assessing and integrating the physiological, neurobiological, and behavioral data collected as part of the proposed studies, we will be able to identify a novel mechanism underlying risk for aging-related health disparities in the female brain.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Georgia
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 397% from $746,124 to $3,710,394.
Emory University was awarded
Stress Exposure Impact on Estradiol-Induced Neuroinflammation Cognition
Project Grant R01AG078248
worth $3,710,394
from National Institute on Aging in September 2022 with work to be completed primarily in Georgia United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.866 Aging Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 6/5/26
Period of Performance
9/1/22
Start Date
5/31/27
End Date
Funding Split
$3.7M
Federal Obligation
$0.0
Non-Federal Obligation
$3.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to R01AG078248
Additional Detail
Award ID FAIN
R01AG078248
SAI Number
R01AG078248-2754568750
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NN00 NIH National Insitute on Aging
Awardee UEI
S352L5PJLMP8
Awardee CAGE
2K291
Performance District
GA-90
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute on Aging, National Institutes of Health, Health and Human Services (075-0843) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,490,557 | 100% |
Modified: 6/5/26